Live Breaking News & Updates on Pratteln

Stay updated with breaking news from Pratteln. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Santhera Publishes Agenda for its Annual General Meeting

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on June 18, 2024, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland. The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at https://www.santhera.com/share-bondholder-me ....

Switzerland General , United Kingdom , United States , Eva Kalias , European Medicines Agency , Members Of The Compensation Committee , Santhera Pharmaceuticals , Regulatory Agency , Drug Administration , Santhera Pharmaceuticals Holding , Head Investor Relations Communications , America To Catalyst Pharmaceuticals Inc , Annual General Meeting , Annual Report , Annual Financial Statements , Consolidated Financial Statements , Annual Result , Compensation Report , Executive Management , Financial Year , North America , Catalyst Pharmaceuticals , Head Investor Relations ,

Santhera Pharmaceuticals Holding AG: Santhera Publishes Annual Report 2023

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 - Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2023 with fully audited results ....

Switzerland General , Eva Kalias , Head Investor Relations Communications , Santhera Pharmaceuticals Holding , Santhera Pharmaceuticals , Annual Report , General Meeting , Head Investor Relations , Ihr Portfolio ,